HIV Vaccine Phase 1 Trial Begins in the US and South Africa
National Institutes of Health
Novel vaccine uses weakened cytomegalovirus as a vector to deliver and alert the immune system
Novel vaccine uses weakened cytomegalovirus as a vector to deliver and alert the immune system
Women with a high DNA methylation score would be prone to HPV infection, AIS, and ADC
This largest study and only case series examines reinfections and infections after a complete MVA–BN vaccine course
Increased investments, innovation, and focus on equity are vitally needed to end the HIV epidemic